Vol 22, No 4 (2016)

Table of Contents

Cover

COVER
 
PDF
89

Contents

CONTENTS
 
PDF
90

Editorial

Can we prevent the transmission of tuberculosis?
Stephanus Malherbe
PDF
91

Original research

The diagnostic gap: Characterising the profile of undiagnosed infectious tuberculosis patients in the community
Greg Calligaro, A Esmail, T Mnguni, L Mottay, K Dheda
PDF
93

Reviews

THe use of macrolides and corticosteroids as immunomodulators in community-acquired pneumonia
Alan Peter
PDF
98

Case reports

Massive haemoptysis in pregnancy
S Mothilal, A Esmail, K Dheda
PDF
101

Breath-taking News

BMPR2 mutations and survival in pulmonary arterial hypertension: An individual participant data meta-analysis
 
PDF
105
Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis
 
PDF
106
Present and future utility of CT phenotypes in the assessment and management of COPD
 
PDF
107

Articles

‘On the shoulders of giants’ – The evolution of paediatric pulmonology in South Africa
Aneesa Vanker
PDF
103

Who's Who

Who’s Who
 
PDF
104

Product News

AstraZeneca Pharmaceuticals responds to the chronic obstructive pulmonary disease crisis with the launch of a non-interventional study – COPVAR
 
PDF
108
NEW Antistatic Chamber: small, solid and effective
 
PDF
110
Rivaroxaban reduces length of hospital stay in patients with symptomatic venous thromboembolism
 
111

SATS Awards

SATS Awards 2016
 
PDF
112